Aclaris therapeutics to participate in the piper sandler 36th annual healthcare conference

Wayne, pa., nov. 26, 2024 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the aclaris management team will participate in a fireside chat during the piper sandler 36th annual healthcare conference on tuesday, december 3, 2024 at 1:00 pm et in new york, new york. a webcast of the fireside chat may be accessed through the “events” page of the “investors” section of aclaris' website, www.aclaristx.com.
ACRS Ratings Summary
ACRS Quant Ranking